| J9035 | Injection, bevacizumab, 10 mg | 23 | 20 | 370 | $2,820 | $2.3M |
| 67210 | The provider destroys a lesion of the retina using a laser beam that heats up the tissue. | 6 | 10 | 90 | $370 | $235.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 5 | 30 | 1,090 | $130 | $222.2K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 2 | 10 | 110 | $510 | $153.3K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 24 | 350 | 540 | $50 | $96.4K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 7 | 120 | 180 | $80 | $62.9K |
| C9257 | Injection, bevacizumab, 0.25 mg | 3 | 20 | 350 | $50 | $61.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2 | 80 | 650 | $20 | $43.1K |
| 92002 | The provider performs an intermediate level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program. | 55 | 440 | 370 | $40 | $38.5K |
| 92015 | The provider determines the process of determining if a patient's vision is less than 20/20 and by what amount so that corrective lenses or contact lenses can be prescribed and produced. | 304 | 530 | 630 | $20 | $32K |